F.D.A. Deals Setback to Catalyst in Race for Drug Approval
By SABRINA TAVERNISE
Catalyst Pharmaceuticals, vying for exclusive rights to a drug that treats a rare neuromuscular condition, received a letter saying its application was incomplete.
Published: February 17, 2016 at 07:00PM
from NYT Health http://ift.tt/1PR2Puz
F.D.A. Deals Setback to Catalyst in Race for Drug Approval SABRINA TAVERNISE Catalyst Pharmaceuticals, vying for exclusive rights to a drug that treats a rare neuromuscular condition, received a letter saying its application was incomplete. http://ift.tt/1PR2Puz Health The New York Times February 17, 2016 at 07:00PM